High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S. - The New York Times

High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S. - The New York Times: Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.